Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Friday 3 May 2019

Investor Ideas Adds New #Stocks in Mining, Cannabis and Defense (CSE: $BJB.C) (CSE: $KMI.C) (CSE: $RAIN.C) (TSXV: $EAST.V) (OTC: $FRLI) (TSXV: $SCAN.V)

Investor Ideas Adds New #Stocks in Mining, Cannabis and Defense (CSE: $BJB.C) (CSE: $KMI.C) (CSE: $RAIN.C) (TSXV: $EAST.V) (OTC: $FRLI) (TSXV: $SCAN.V)



Point Roberts WA, Delta BC – May 3, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in mining, cannabis and defense.


The newest mining stocks are all listed on the TheCSE.com (Canadian Stock Exchange) and are currently operating in Canada.

The latest cannabis companies include a wellness company looking to become a global giant in the Hemp & CBD consumer health market and a biotech company using human DNA gene sequencing and artificial intelligence (AI) that has a signed an agreement with a leader in the consumer hemp extract market to provide DNA kits to help consumers find products best suited to their unique DNA profile.

And finally, the newest defense company, Liberty Defense Holdings, Ltd. (TSX: SCAN.V) provides security solutions for concealed weapon detection in high volume foot traffic areas.

New Mining Companies:
Bond Resources Inc. (CSE:BJB) is a mineral exploration company holding a 100% interest in a mineral property more commonly known as the Aspen Property, situated in the Nechako Plateau in British Columba, Canada.

Karam Minerals Inc. (CSE:KMI) is a resource exploration company focused on the acquisition, evaluation and exploration of mineral resource properties.

Rain City Resources Inc. (CSE:RAIN) is a Vancouver based mineral exploration company focused on base, rare earth elements, precious metals and gems exploration in North America. The company is currently exploring the Similkameen Mining Division of British Columbia.

New Cannabis Companies:
EastWest Bioscience Inc. (TSX:EAST.V) is a vertically integrated wellness company with the infrastructure to become a global giant in the Hemp & CBD consumer health market. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium hemp products. EastWest is strategically positioned in mainstream consumer markets with wholistic natural products and has developed distribution channels into mainstream stores and markets in Canada. The Company has a Health Canada licensed, GMP (Good Manufacturing Practices) certified manufacturing facility and produces premium brands offering natural products for a preventive care lifestyle. EastWest consumer product lines are divided into four distinct brands: 1) Natural Advancement - natural biopharmaceutical health supplements; 2) Earth's Menu - all-natural hemp superfoods; 3) Natural Pet Science - pet food and pet supplements; and 4) Chanvre Hemp - all-natural health and beauty products. The organization will continue to focus on ongoing development of innovative, hemp-based consumer products through advanced science with clean, natural ingredients to complement its current product offerings.

Frelii Inc. (OTCQB: FRLI) is a biotech company that uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The results are aligned and leveraged against its AI, as a means of creating a very strong and powerful data platform for use by the Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical industries. Frelii’s technology generates accurate and profoundly valuable insight into an individual’s DNA. The company provides DNA Kit Packages and customized reporting for consumers, patients and healthcare providers to ensure the ideal treatment, drugs and dosing are a prime “fit” to the individual. Cannabis – Maya 2019 - announced that it has signed a contract and licensing agreement with Optivida Health (Optivida), one of the nation’s leaders in advanced hemp extract for the consumer market. Optivida will leverage Frelii’s proprietary DNA Kit Packages™ to ensure Optivida customers can realize the optimal benefits of which specific Optivida products best suit their unique DNA profile.

New Defense Companies:
Liberty Defense Holdings, Ltd. (TSX: SCAN.V) provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive licence from MIT Lincoln Laboratory, as well as a technology transfer agreement, for patents related to active 3D imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to proactively counter evolving urban threats. The sensors with active 3D imaging and AI-enhanced automatic detection are designed to detect metallic and non-metallic firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411





#CBD Gets Better and Bolder: #Hemp CBD Companies Find New Distribution and Innovations (OTC: $HIPH) (OTC: $LRSV) (OTC: $CVSI) (OTC: $GDET)


#CBD Gets Better and Bolder: #Hemp CBD Companies Find New Distribution and Innovations (OTC: $HIPH) (OTC: $LRSV) (OTC: $CVSI) (OTC: $GDET)



Point Roberts WA, Delta BC – May 3, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the hemp and CBD oil sector and how as the market gets crowded with CBD products, companies are betting on innovation and new distribution to help them stand out.

We’ve been hearing constantly about CBD, ever since the passing of the 2018 Farm Bill, but how can any one company hope to stand out in such an ever-growing crowd? The answer that seems to be appearing more often is unique and innovative product offerings along with unique distribution arrangements.

American Premium Water Corporation (OTC: HIPH) announced that it has entered into a letter of intent with Link Reservation, Inc. (OTC: LRSV) to form a joint-venture to produce a CBD-infused water specifically designed for consumption by household pets. This product will be the first pet CBD beverage on the market which allows both companies to be in a unique position moving forward. It will be sold under the LinkRes Pet brand “powered by” LALPINA CBD. The product is expected to be released in 2019.   
     

CEO of American Premium Water Corporation, Ryan Fishoff commented, “I am excited to announce this joint venture with LinkRes Pets to produce the first CBD-beverage for pets! The consumer market is huge, and there are many studies that have shown how pet health can benefit from consumption of CBD. This is a great partnership for the Company. We will be providing our proprietary Hydro-Nano formulation to be used in the manufacture of the product by LinkRes. They will handle logistics and distribution; while the Company will assist with marketing. This partnership will provide great exposure for the LALPINA CBD brand. Every pet owner is also a potential customer for our LALPINA CBD water. Pet owners statistically are more affluent than non-pet owners; co-branding with LinkRes will bring additional exposure to our Company to a very captive consumer base.”   

In mid- April American Premium Water also announced that the Company had received a two container order from a distributer in the UK. The order is expected to ship out during the 2nd quarter and be reflected in the subsequent Q2 financials. Based on the expectation of residual orders from this distributor and other pending distribution deals, the Company is announcing guidance for fiscal year 2019 of at least $1 million in expected revenue.

Rene Lauritsen, President and CEO of LinkRes Pets commented, “It is great to partner with a company like American Premium Water Corp. Their Hydro Nano technology is very advanced in the marketplace that is backed with scientific data, which aligns with the LinkRes brand. Co-branding with the LALPINA CBD is the key element that will be essential for a successful launch creating this brand new product category (Pet CBD Beverages). This partnership will be very impactful for LinkRes Pets, and I look forward to working with Ryan and his team in the coming months developing this product.”

LinkRes Pets (www.linkrespet.com) produces CBD products specifically tailored for cats, dogs and horses. LinkRes current product offering is exclusively CBD oil. The partnership with American Premium Water would be their first product outside of CBD oil. The American Pet Products Association estimates that the US pet product industry will be worth over $75 billion in 2019. New Frontier Data projects that the CBD Pet Product Market will reach $125 million in sales by 2022. And according to a report by Research and Marketing, over 55% of US households own a pet, and are more likely to be in a higher income household than non-pet owners.

“There is a huge opportunity with this partnership. Currently there are no pet CBD beverages on the market, and the pet beverage market itself is very limited and underdeveloped. We are going to be starting out with a huge head start. This product has the potential to add $1-3 million dollars of incremental revenue to the P&L once full distribution is reached. This partnership is an example of how the Company’s IP and technology acquisition strategy is paying dividends. The Company is leveraging its proprietary Hydro-Nano formulation to generate incremental revenue. The Company will continue to seek partnership opportunities in new categories, similar to our partnership with Hanlon’s Brewery in the UK. We are currently engaged in discussions with other potential partners about leveraging the Company’s technology into new product categories and applications. I look forward to providing shareholders with updates on these conversations when developments are ready to share.” concluded Mr. Fishoff.

CV Sciences, Inc. (OTC: CVSI), a preeminent supplier and manufacturer of hemp CBD products, recently announced further expansion of its industry-dominating brand, PlusCBD Oil™. As of March 31, 2019, PlusCBD Oil™ branded products are available in 3,308 retail stores, up 48% from 2,238 retail stores as of December 31, 2018.

The expansion includes broadening distribution of its best-selling topical, PlusCBD Oil™ Extra Strength Balm, into the Food, Drug and Mass (FDM) channel, including programs with leading national retailers.

“The passage of the 2018 Farm Bill has accelerated our business development activities and expanded our distribution to new food, drug, mass merchandise retailers,” said Joseph Dowling, Chief Executive Officer. “We are at an important stage in the development of the hemp-based CBD market, and the company is well-positioned to capitalize on both growing consumer demand and the benefit of enhanced regulation that supports and ensures the safest and highest quality hemp-based CBD products for consumers.”

The company also announced that it will release financial results for its first quarter 2019 ended March 31, 2019, after the stock market closes on Wednesday, May 8, 2019. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.
The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=134448. The webcast will be archived for approximately 30 days.
GD Entertainment And Technology (OTC: GDET) has also garnered new distribution for their unique products having recently announced that the company’s Hemp Derived CBD wellness and cosmetic products will now be available on EBAY (www.EBAY.com/thegreeneryshop).  The Company launched its brand-new Hemp Derived CBD product line last weekend in conjunction with the annual 420 celebration. Sales have been even better than expected.  In addition to now being available online at EBAY, GDET's The Greenery hemp derived CBD wellness and cosmetic products are also available at www.thegreeneryco.com.  

The company also announced that Goldman Small Cap Research issued a research report on the Company. The report includes a target price-per-share of $0.06. The report reviews recent events and provides an analysis of GDET's new initiatives. To view the research report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com.

As mentioned above, CBD news is and will most likely continue to be non-stop for 2019 which means each company in the space will have to work harder to stand out and secure early distribution. While this may be stressful for companies currently in this space, or thinking of entering, this is a massive boon for US customers who will soon have easy access to a vast array of impressive hemp derived/CBD products.


For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Follow us on Cannabis Social Media

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp  Disclosure : this article featuring  HIPH is a paid for service on Investorideas ( two thousand third party ) . Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411



Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Thursday 2 May 2019

Investorideas.com - Cannabis stock news: Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) Teams with Highmark Interactive to Sponsor Clinical Research in CBD

Investorideas.com - Cannabis stock news: Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) Teams with Highmark Interactive to Sponsor Clinical Research in CBD

Investorideas.com - Pure Harvest Cannabis Group (OTC PINK: PCKK) Completes Name & Symbol Change, Forward Split

Investorideas.com - Pure Harvest Cannabis Group (OTC PINK: PCKK) Completes Name & Symbol Change, Forward Split

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $SLNG.C) (NYSE: $CGC) (CSE: $TER.C) (CSE: $MYM.C) (CSE: $CURA.C)


Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $SLNG.C) (NYSE: $CGC) (CSE: $TER.C) (CSE: $MYM.C) (CSE: $CURA.C)



Delta, Kelowna, BC –May 2, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at


Today’s podcast overview/transcript:
Good morning and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast I focus on a few early announcements from some interesting companies.

SLANG Worldwide Inc. (CSE: SLNG), a leading global cannabis consumer packaged goods company with a robust portfolio of renowned brands distributed across 2,600 stores in 11 US states, announced the establishment of its new wellness-focused business division, SLANG Health and Wellness. The new business unit will develop and market a portfolio of plant-based cannabidiol products that will be distributed in partnership with Greenlane Holdings, Inc. (NASDAQ: GNLN) through their extensive distribution network.

"Consumers are increasingly interested in natural plant-based wellness products, and we've only scratched the surface of the opportunity within cannabinoid-supported wellness," said SLANG CEO Peter Miller. "Health and Wellness represents a new market segment for SLANG and is a natural extension for our portfolio of top selling products across the US and internationally. We expect early sales to be supported by the brand awareness and customer loyalty that we've developed within our existing portfolio over many years of innovation and
consumer focus."

SLANG Health and Wellness products will target a rapidly expanding and promising consumer market that is expected to grow from US$591 million in 2018 to US$22 billion by 2022, according to The Brightfield Group. The Company will initially focus on extending SLANG's existing industry leading portfolio of THC-dominant products into the CBD space and will immediately launch sales of the Company's best-selling O.penVAPE Reserve brand, to be sold as a half gram hemp-based CBD cartridge.

Canopy Growth Corporation(TSX: WEED) (NYSE: CGC) announced that it has acquired German-based, Bionorica SE-founded C3 Cannabinoid Compound Company in a transformative deal that will see established single cannabinoid medicines brought together with the world's leading full-spectrum medical cannabis offering.
                             
The all cash-acquisition for €225.9 million (CDN $342.9 million) furthers Canopy Growth's expansion into European markets with prescription medicines and gives the Company immediate access to a wealth of knowledge and intellectual property that C3 has developed in its nearly 20 years of research and development into synthetic and natural cannabis medical products.

C3's primary medicinal offering is dronabinol, a pure chemical compound with standardized concentrations of tetrahydrocannabinol (THC), one of the active ingredients found in cannabis plants that is responsible for various pharmacological effects. Dronabinol is available in Austria, Denmark, and Germany for nausea and vomiting refractory to conventional treatment in oncology and palliative care, and for cancer pain. In Germany, dronabinol can be prescribed for any type of chronic pain and for any condition in palliative care. C3 has a total of five medicines in the market and its commercial operations generated €27.1 million (CDN $41.5 million) in 2018.
                             
The acquisition will allow Canopy Growth to further empower European physicians with the knowledge and therapies drawn from the full range of synthetic to naturally-derived cannabinoid-based medicines. Adding dronabinol to Canopy Growth's product offering in Europe and potentially other key markets will allow the Company's medical division, Spectrum Cannabis, to present an expanded, medically validated suite of cannabinoid therapies to the benefit of healthcare professionals and patients. Furthermore, C3's infrastructure including production, distribution, and sales & marketing significantly adds to the Spectrum Cannabis footprint in Europe, including an expanding product line and additional reach into pharmacy and medical specialists' networks.

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) today announced that its manufacturing facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice certificate in accordance with the rules governing medicinal products in the European Union.

The EU GMP certification was awarded by the responsible agency, Arzneimittelbehörde, in North Rhine-Westphalia, Germany. Additionally, the Company has entered a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler with a cannabis-specific import and distribution license. TerrAscend expects to begin distribution through iuvo this quarter.

"Just five months ago, TerrAscend became the first North American Operator (NAO), with scale operations in both Canada and the US. Upon commencement of shipments this quarter, through our partner iuvo in Germany, TerrAscend will be the first and only global cannabis operator with sales in the three largest markets in the world," said Dr. Michael Nashat, CEO of TerrAscend. "We will continue to expand our sales footprint going forward and will share news of these milestones as we achieve them."

MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) announced that the Company has acquired 50% of BioHemp Naturals ("BioHemp"), a licensed hemp cultivator in the business of cultivating and distributing CBD-rich hemp biomass to licensed producers in Canada. BioHemp co-founder, Len Atkinson, will join the MYM management team as Global Hemp Project Manager.

BioHemp's founder has been growing hemp since 2015 and developed unique harvesting methods and standard operating procedures which meet all Health Canada testing requirements for hemp. BioHemp is expanding its hemp operations to cultivate 450 acres this 2019 season with plans to expand to 3,000 acres of certified organic hemp in 2020. Forecasted revenues based on the sale of biomass for the 2019 grow season are expected to exceed $30 million with 2020 grow season $225 million.The partnership will allow BioHemp to toll-process the hemp flower through MYM's planned extraction plant which would significantly increase revenues for both seasons.

"Acquiring 50% of BioHemp Naturals and engaging Mr. Atkinson as MYM's Global Hemp Project Manager is a huge win for MYM and our stated goal to become global CBD-rich hemp cultivators, extractors, and distributors," said Howard Steinberg, CEO of MYM. "The addition of BioHemp Naturals adds over 3,000 acres of cultivation to the company which is expected to significantly increase future revenues of MYM."

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ,  a leading vertically integrated cannabis operator in the United States, unveiled its new Arizona initiative with the Veterans Cannabis Project (VCP), an organization that advocates for legal and supported access of medical cannabis for veterans through the Department of Veterans Affairs. Patients at Curaleaf's five Arizona locations can purchase a custom-designed "Veterans Cannabis Project" pre-roll product, with a portion of all proceeds benefiting the VCP. Each box includes five pre-rolls and will be available for $16.

Veterans and concerned citizens also participated in the launch of a nationwide petition and grassroots campaign supporting medical cannabis. The campaign urges Congress to authorize access, provide protections, and require research into medical cannabis. Additionally, it calls for the Department of Veterans Affairs to give veterans access to the cannabis they overwhelmingly want and deserve.  The petition can be accessed here: https://www.vetscp.org/act.

To celebrate the launch, local veterans visited Curaleaf's Midtown location to hear Dr. Sue Sisley, an Arizona scientist who conducted the first FDA-approved study of cannabis for PTSD in veterans, speak about her recent research. Steve Cottrell, President of Curaleaf Arizona, and Doug Distaso, Executive Director of VCP, also spoke about the new initiative aimed at raising awareness and support around veterans' access.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411




 Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories




Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">

Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX...